Originally published March 1 2005
Germany restricts use of Cox-2 inhibitors, even as FDA decides they are safe
by Mike Adams, the Health Ranger, NaturalNews Editor
The U.S. may have decided that Cox-2 inhibitors are safe to rejoin the market but German officials are not agreeing. Officials caution that anyone that has had heart problems or suffered from a stroke should discontinue use of the drugs immediately. Further research will be conducted and a report is expected in April regarding the Germans take on the class of drugs.
Germany will issue guidelines in the next few days to significantly restrict the use of so-called COX-2 inhibitors to ease pain, the country's drug regulator said on Monday.
Patients who either have had a heart attack or stroke, suffer from circulatory disorders of the heart or are at a high risk of developing such conditions should no longer use the medications, the regulator said in a statement.
The regulator's remarks come close on the heels of comments by a U.S. advisory panel on Friday that Merck & Co Inc.'s withdrawn COX-2 inhibitor arthritis drug, Vioxx, was safe enough to rejoin Pfizer's rival pain relievers, Celebrex and Bextra, on the U.S. market.
The German regulator said patients with high blood pressure that can not be stabilized also should not use etoricoxib, another name for Merck & Co's Arcoxia.
The German regulator said that COX-2 inhibitors-- the general category to which Arcoxia, Vioxx, Celebrex and Bextra belong -- should be taken only in the smallest possible effective dose and only as long as absolutely needed.
It said that a risk evaluation process in the European Union for the class of COX-2 inhibitors was continuing and that a report was expected in April.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml